Letters sent to healthcare professionals in June 2016

In June 2016, a letter was sent to healthcare professionals about Thalidomide Celgene.

• From: Medicines and Healthcare products Regulatory Agency
• Published: 18 July 2016

• Therapeutic area: Cancer

On 20 June 2016, a letter was sent to healthcare professionals about Thalidomide Celgene: risks of viral reactivation and pulmonary hypertension associated with Thalidomide Celgene.

Published 18 July 2016